Cargando…

Research progress on molecular biomarkers of acute myeloid leukemia

Acute myeloid leukemia (AML) is the most common type of adult acute leukemia. The pathophysiology of the disease has been studied intensively at the cellular and molecular levels. At present, cytogenetic markers are an important basis for the early diagnosis, prognostic stratification and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Pei-Yuan, Wang, Rui-Wen, Jing, Rui, Li, Xing, Ma, Jing-Hua, Li, Kai-Min, Wang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941555/ https://www.ncbi.nlm.nih.gov/pubmed/36824144 http://dx.doi.org/10.3389/fonc.2023.1078556

Ejemplares similares

Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
por: Jamal, Muhammad, et al.
Publicado: (2019)

SPRED1 Is Downregulated and a Prognostic Biomarker in Adult Acute Myeloid Leukemia
por: Zhang, Rui, et al.
Publicado: (2020)

The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
por: Huang, Wanxue, et al.
Publicado: (2022)

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
por: Wang, Yin, et al.
Publicado: (2021)

A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia
por: Yu, Yang, et al.
Publicado: (2023)

Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia
por: Wiatrowski, Kyle, et al.
Publicado: (2022)

Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
por: Lu, Rui, et al.
Publicado: (2017)

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
por: Zhuang, Xiaomei, et al.
Publicado: (2022)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022)

The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia
por: Shi, Yuanfei, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression
por: Yin, Kai, et al.
Publicado: (2020)

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
por: Su, Nan, et al.
Publicado: (2022)

Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy
por: Zhang, Yi, et al.
Publicado: (2022)

Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
por: Li, Mei-Yong, et al.
Publicado: (2021)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014)

MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia
por: Niu, Mingshan, et al.
Publicado: (2019)

Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
por: Zhong, Fang-Min, et al.
Publicado: (2022)

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia
por: Sun, Younguk, et al.
Publicado: (2018)

Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia
por: Bai, Shenrui, et al.
Publicado: (2023)

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
por: Zhao, Guangjie, et al.
Publicado: (2021)

Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia With Losing Major Molecular Response as a Definition for Molecular Relapse: A Systematic Review and Meta-Analysis
por: Chen, Kang-kang, et al.
Publicado: (2019)

Identification of U937(JAK3-M511I) Acute Myeloid Leukemia Cells as a Sensitive Model to JAK3 Inhibitor
por: Si, Hongfei, et al.
Publicado: (2022)

Acute Promyelocytic Leukemia Presenting With a Myeloid Sarcoma of the Spine: A Case Report and Literature Review
por: Shu, Xuemei, et al.
Publicado: (2022)

Case report: A rare case of acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia
por: Zhao, Junmei, et al.
Publicado: (2022)

Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells
por: Chen, Yilin, et al.
Publicado: (2021)

Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression
por: Zhang, Wenwen, et al.
Publicado: (2021)

Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic CEBPA Mutations Based on a Multi-Gene Panel and Nomogram Model
por: Wu, Li-Xin, et al.
Publicado: (2021)

Editorial: Research progress on immune microenvironment and molecular mechanism of glioma
por: Marei, Hany E., et al.
Publicado: (2023)

Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
por: Zhang, Hui, et al.
Publicado: (2020)

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis
por: Guarnera, Luca, et al.
Publicado: (2022)

Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia
por: Ramakrishnan, Anitha, et al.
Publicado: (2023)

Identification of autophagy-associated genes and prognostic implications in adults with acute myeloid leukemia by integrated bioinformatics analysis
por: Zhang, Jing, et al.
Publicado: (2023)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia
por: Xiao, Qiaoling, et al.
Publicado: (2022)

Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia
por: Zhou, Cheng, et al.
Publicado: (2022)

Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
por: Wilde, Lindsay, et al.
Publicado: (2019)

Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies
por: El Achi, Hanadi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9f7vhcatbsndohr8nk63brn0oc